RECURRENT GLIOMA TX
Phase I trial in recurrent high-grade glioma: High-dose vorinostat with concurrent hypofractionated radiation therapy
| Coordinator | MEDICAL RESEARCH INFRASTRUCTURE DEVELOPMENT AND HEALTH SERVICES FUND BY THE SHEBA MEDICAL CENTER |
| Grant period | 2013-01-01 - 2016-12-31 |
| Funding body | European Union |
| Call number | FP7-PEOPLE-2011-CIG |
| Grant number | 303795 |
| Identifier | G:(EU-Grant)303795 |